CIBINQO Who should not take CIBINQO?

(abrocitinib)

Who should not take CIBINQO?

Do not take CIBINQO if you take medicines that prevent blood clots (antiplatelet medicines), except for low-dose aspirin up to a dose of 81 mg each day during the first 3 months of CIBINQO treatment.

Before taking CIBINQO, tell your healthcare provider about all of your medical conditions, including if you:

•
See "What is the most important information I should know about CIBINQO?"
•
have an infection
•
are a current or past smoker
•
have had a heart attack, other heart problems, or stroke
•
have kidney problems or liver problems
•
have low platelet counts or white blood cell counts
•
have high levels of fat in your blood (high cholesterol)
•
have any eye problems, including cataracts or retinal detachment.
•
have recently received or are scheduled to receive an immunization (vaccine). People who take CIBINQO should not receive live vaccines.
•
are pregnant or plan to become pregnant. It is not known if CIBINQO will harm your unborn baby.
o
Pregnancy Exposure Registry. Pfizer has a registry for women who take CIBINQO during pregnancy. The purpose of this registry is to check the health of you and your baby. If you are pregnant or become pregnant during treatment with CIBINQO, talk to your healthcare provider about how you can join this pregnancy registry, or you may contact the registry at 1-877-311-3770 or www.cibinqopregnancyregistry.com.
•
are breastfeeding or plan to breastfeed. It is not known if CIBINQO passes into your breast milk. You and your healthcare provider should decide if you will take CIBINQO or breastfeed. You should not do both.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. CIBINQO and other medicines may affect each other causing side effects.
Especially tell your healthcare provider if you take aspirin or any antiplatelet therapies (See the "Who should not take CIBINQO?" section). Ask your healthcare provider if you are unsure.
Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist whenever you get a new medicine.

Find CIBINQO medical information:

Find CIBINQO medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

CIBINQO Quick Finder

Medication Guide

Health Professional Information

Who should not take CIBINQO?

Who should not take CIBINQO?

Do not take CIBINQO if you take medicines that prevent blood clots (antiplatelet medicines), except for low-dose aspirin up to a dose of 81 mg each day during the first 3 months of CIBINQO treatment.

Before taking CIBINQO, tell your healthcare provider about all of your medical conditions, including if you:

•
See "What is the most important information I should know about CIBINQO?"
•
have an infection
•
are a current or past smoker
•
have had a heart attack, other heart problems, or stroke
•
have kidney problems or liver problems
•
have low platelet counts or white blood cell counts
•
have high levels of fat in your blood (high cholesterol)
•
have any eye problems, including cataracts or retinal detachment.
•
have recently received or are scheduled to receive an immunization (vaccine). People who take CIBINQO should not receive live vaccines.
•
are pregnant or plan to become pregnant. It is not known if CIBINQO will harm your unborn baby.
o
Pregnancy Exposure Registry. Pfizer has a registry for women who take CIBINQO during pregnancy. The purpose of this registry is to check the health of you and your baby. If you are pregnant or become pregnant during treatment with CIBINQO, talk to your healthcare provider about how you can join this pregnancy registry, or you may contact the registry at 1-877-311-3770 or www.cibinqopregnancyregistry.com.
•
are breastfeeding or plan to breastfeed. It is not known if CIBINQO passes into your breast milk. You and your healthcare provider should decide if you will take CIBINQO or breastfeed. You should not do both.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. CIBINQO and other medicines may affect each other causing side effects.
Especially tell your healthcare provider if you take aspirin or any antiplatelet therapies (See the "Who should not take CIBINQO?" section). Ask your healthcare provider if you are unsure.
Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist whenever you get a new medicine.
Prescribing Information
Download Prescribing Information

Health Professional Information

Who should not take CIBINQO?

Who should not take CIBINQO?

Do not take CIBINQO if you take medicines that prevent blood clots (antiplatelet medicines), except for low-dose aspirin up to a dose of 81 mg each day during the first 3 months of CIBINQO treatment.

Before taking CIBINQO, tell your healthcare provider about all of your medical conditions, including if you:

•
See "What is the most important information I should know about CIBINQO?"
•
have an infection
•
are a current or past smoker
•
have had a heart attack, other heart problems, or stroke
•
have kidney problems or liver problems
•
have low platelet counts or white blood cell counts
•
have high levels of fat in your blood (high cholesterol)
•
have any eye problems, including cataracts or retinal detachment.
•
have recently received or are scheduled to receive an immunization (vaccine). People who take CIBINQO should not receive live vaccines.
•
are pregnant or plan to become pregnant. It is not known if CIBINQO will harm your unborn baby.
o
Pregnancy Exposure Registry. Pfizer has a registry for women who take CIBINQO during pregnancy. The purpose of this registry is to check the health of you and your baby. If you are pregnant or become pregnant during treatment with CIBINQO, talk to your healthcare provider about how you can join this pregnancy registry, or you may contact the registry at 1-877-311-3770 or www.cibinqopregnancyregistry.com.
•
are breastfeeding or plan to breastfeed. It is not known if CIBINQO passes into your breast milk. You and your healthcare provider should decide if you will take CIBINQO or breastfeed. You should not do both.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. CIBINQO and other medicines may affect each other causing side effects.
Especially tell your healthcare provider if you take aspirin or any antiplatelet therapies (See the "Who should not take CIBINQO?" section). Ask your healthcare provider if you are unsure.
Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist whenever you get a new medicine.

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Contact Medical Information.9AM-5PM ET Monday to Friday; excluding holidays.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.